CLINICAL_TRIALS
trial_result
· 2019-06-12
Clinical Trial Update: A Phase 1 Study of LY2874455 in Participants With Advanced Cancer [Phase 1]
Summary
Phase 1 study of LY2874455 in participants with advanced cancer has completed; results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Advanced Cancer | Phase 1 | Status: COMPLETED | Results posted: 2019-06-12